{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:40Z","timestamp":1792784260875,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:00:00Z","timestamp":1543449600000},"content-version":"am","delay-in-days":301,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81673485"],"award-info":[{"award-number":["81673485"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81473208"],"award-info":[{"award-number":["81473208"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81422049"],"award-info":[{"award-number":["81422049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81671304"],"award-info":[{"award-number":["81671304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81370558"],"award-info":[{"award-number":["81370558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National 863 Plan Young Scientist Program of China","award":["2015AA020943"],"award-info":[{"award-number":["2015AA020943"]}]},{"DOI":"10.13039\/501100010032","name":"Shanghai Municipal Health and Family Planning Commission Foundation","doi-asserted-by":"publisher","award":["2016ZB0306"],"award-info":[{"award-number":["2016ZB0306"]}],"id":[{"id":"10.13039\/501100010032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.metabol.2017.11.002","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T02:33:16Z","timestamp":1510281196000},"page":"52-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Nicotinic acetylcholine receptor \u03b17 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"79","author":[{"given":"Dong-Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Bo","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Ming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1650-3353","authenticated-orcid":false,"given":"Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6037","key":"10.1016\/j.metabol.2017.11.002_bb0005","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0010","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease","volume":"65","author":"Fazel","year":"2016","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0015","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.metabol.2016.04.004","article-title":"Pharmacological management of nonalcoholic fatty liver disease","volume":"65","author":"Barb","year":"2016","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0020","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.metabol.2016.01.013","article-title":"Noninvasive diagnosis of nonalcoholic fatty liver disease: are we there yet?","volume":"65","author":"Alkhouri","year":"2016","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0025","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.metabol.2015.12.009","article-title":"Nonalcoholic fatty future disease","volume":"65","author":"Polyzos","year":"2016","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0030","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.metabol.2015.08.018","article-title":"Genetics of nonalcoholic fatty liver disease","volume":"65","author":"Dongiovanni","year":"2016","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0035","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.metabol.2017.11.002_bb0040","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.metabol.2016.06.006","article-title":"Lipid phenotypes in patients with nonalcoholic fatty liver disease","volume":"65","author":"Du","year":"2016","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.metabol.2017.11.002_bb0045","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-Jarvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0050","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","article-title":"Non-alcoholic fatty liver disease and dyslipidemia: an update","volume":"65","author":"Katsiki","year":"2016","journal-title":"Metabolism"},{"issue":"323","key":"10.1016\/j.metabol.2017.11.002_bb0055","doi-asserted-by":"crossref","first-page":"323rv1","DOI":"10.1126\/scitranslmed.aad8390","article-title":"The intersection of nonalcoholic fatty liver disease and obesity","volume":"8","author":"Woo Baidal","year":"2016","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0060","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","article-title":"Non-alcoholic fatty liver disease and diabetes","volume":"65","author":"Hazlehurst","year":"2016","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.metabol.2017.11.002_bb0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0070","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.metabol.2015.11.006","article-title":"Adipokines in nonalcoholic fatty liver disease","volume":"65","author":"Polyzos","year":"2016","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0075","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.metabol.2015.09.017","article-title":"Non-alcoholic fatty liver disease and risk of cardiovascular disease","volume":"65","author":"Lonardo","year":"2016","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.metabol.2017.11.002_bb0080","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/hep.23516","article-title":"Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats","volume":"51","author":"Azzalini","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.metabol.2017.11.002_bb0085","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/hep.23751","article-title":"Smoking is associated with histological severity in nonalcoholic steatohepatitis","volume":"52","author":"Tsochatzis","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.metabol.2017.11.002_bb0090","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jhep.2010.07.040","article-title":"Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease","volume":"54","author":"Zein","year":"2011","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.metabol.2017.11.002_bb0095","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00535-011-0376-z","article-title":"Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period","volume":"46","author":"Hamabe","year":"2011","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.metabol.2017.11.002_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbrc.2011.10.151","article-title":"Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells","volume":"417","author":"Soeda","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.metabol.2017.11.002_bb0105","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1210\/en.2013-1839","article-title":"Nicotine improves obesity and hepatic steatosis and ER stress in diet-induced obese male rats","volume":"155","author":"Seoane-Collazo","year":"2014","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.metabol.2017.11.002_bb0110","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.3892\/mmr.2015.4318","article-title":"Treatment of experimental non-alcoholic steatohepatitis by targeting alpha7 nicotinic acetylcholine receptor-mediated inflammatory responses in mice","volume":"12","author":"Zhou","year":"2015","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.metabol.2017.11.002_bb0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2012.08.012","article-title":"Nicotinic acetylcholine receptors: from basic science to therapeutics","volume":"137","author":"Hurst","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.metabol.2017.11.002_bb0120","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2174\/1871527313666140711094525","article-title":"Alpha7 neuronal nicotinic receptor: a pluripotent target for diseases of the central nervous system","volume":"13","author":"Bencherif","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"6785","key":"10.1016\/j.metabol.2017.11.002_bb0125","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/35013070","article-title":"Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin","volume":"405","author":"Borovikova","year":"2000","journal-title":"Nature"},{"issue":"6921","key":"10.1016\/j.metabol.2017.11.002_bb0130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","article-title":"Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation","volume":"421","author":"Wang","year":"2003","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0135","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ni1229","article-title":"Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway","volume":"6","author":"de Jonge","year":"2005","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.metabol.2017.11.002_bb0140","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bcp.2015.07.022","article-title":"Alpha7 nicotinic receptor activation protects against oxidative stress via heme-oxygenase I induction","volume":"97","author":"Navarro","year":"2015","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0145","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1096\/fj.14-262493","article-title":"Absence of nicotinic acetylcholine receptor alpha7 subunit amplifies inflammation and accelerates onset of fibrosis: an inflammatory kidney model","volume":"29","author":"Truong","year":"2015","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.metabol.2017.11.002_bb0150","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/bja\/aer202","article-title":"alpha7 nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-alpha production and lung injury","volume":"107","author":"Kox","year":"2011","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1016\/j.metabol.2017.11.002_bb0155","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/art.24470","article-title":"The alpha7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: a possible role for a key neurotransmitter in synovial inflammation","volume":"60","author":"van Maanen","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.metabol.2017.11.002_bb0160","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000358627","article-title":"Activation of alpha7 nicotinic acetylcholine receptor protects against oxidant stress damage through reducing vascular peroxidase-1 in a JNK signaling-dependent manner in endothelial cells","volume":"33","author":"Li","year":"2014","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"10.1016\/j.metabol.2017.11.002_bb0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/HYPERTENSIONAHA.110.160077","article-title":"Dysfunction of the cholinergic anti-inflammatory pathway mediates organ damage in hypertension","volume":"57","author":"Li","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2017.11.002_bb0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2261-12-38","article-title":"Downregulation of alpha7 nicotinic acetylcholine receptor in two-kidney one-clip hypertensive rats","volume":"12","author":"Chen","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.metabol.2017.11.002_bb0175","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/CCM.0b013e31819598f5","article-title":"Antishock effect of anisodamine involves a novel pathway for activating alpha7 nicotinic acetylcholine receptor","volume":"37","author":"Liu","year":"2009","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0180","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1161\/ATVBAHA.116.307157","article-title":"alpha7 nicotinic acetylcholine receptor relieves angiotensin II-induced senescence in vascular smooth muscle cells by raising nicotinamide adenine dinucleotide-dependent SIRT1 activity","volume":"36","author":"Li","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.metabol.2017.11.002_bb0185","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.celrep.2016.02.032","article-title":"Central insulin action activates Kupffer cells by suppressing hepatic vagal activation via the nicotinic alpha 7 acetylcholine receptor","volume":"14","author":"Kimura","year":"2016","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.metabol.2017.11.002_bb0190","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/ALN.0000000000001309","article-title":"Vagus nerve attenuates hepatocyte apoptosis upon ischemia-reperfusion via alpha7 nicotinic acetylcholine receptor on Kupffer cells in mice","volume":"125","author":"Ni","year":"2016","journal-title":"Anesthesiology"},{"issue":"15","key":"10.1016\/j.metabol.2017.11.002_bb0195","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1111\/bph.13513","article-title":"Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing","volume":"173","author":"Zhou","year":"2016","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.metabol.2017.11.002_bb0200","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2337\/db11-1180","article-title":"Loss of AMP-activated protein kinase-\u03b12 impairs the insulin-sensitizing effect of calorie restriction in skeletal muscle","volume":"61","author":"Wang","year":"2012","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.metabol.2017.11.002_bb0205","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/cvr\/cvu056","article-title":"Vascular smooth muscle cell apoptosis is an early trigger for hypothyroid atherosclerosis","volume":"102","author":"Wang","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.metabol.2017.11.002_bb0210","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2337\/db11-1180","article-title":"Loss of AMP-activated protein kinase-alpha2 impairs the insulin-sensitizing effect of calorie restriction in skeletal muscle","volume":"61","author":"Wang","year":"2012","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.metabol.2017.11.002_bb0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nmeth.1806","article-title":"A guide to analysis of mouse energy metabolism","volume":"9","author":"Tschop","year":"2011","journal-title":"Nat Methods"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0220","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.metabol.2017.11.002_bb0225","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1158\/1535-7163.MCT-15-0140","article-title":"Nicotine induces tumor growth and Chemoresistance through activation of the PI3K\/Akt\/mTOR pathway in bladder cancer","volume":"14","author":"Yuge","year":"2015","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.metabol.2017.11.002_bb0230","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nm.3826","article-title":"Activation of AMPKalpha2 in adipocytes is essential for nicotine-induced insulin resistance in vivo","volume":"21","author":"Wu","year":"2015","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.metabol.2017.11.002_bb0235","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/nm.2711","article-title":"Activation of AMP-activated protein kinase alpha2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo","volume":"18","author":"Wang","year":"2012","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.metabol.2017.11.002_bb0240","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/en.2010-0855","article-title":"Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance","volume":"152","author":"Wang","year":"2011","journal-title":"Endocrinology"},{"issue":"20","key":"10.1016\/j.metabol.2017.11.002_bb0245","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1111\/bph.13260","article-title":"alpha7 nicotinic ACh receptor-deficient mice exhibit sustained attention impairments that are reversed by beta2 nicotinic ACh receptor activation","volume":"172","author":"Kolisnyk","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.metabol.2017.11.002_bb0250","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/bph.13001","article-title":"AQW051, a novel, potent and selective alpha7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation","volume":"172","author":"Feuerbach","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.metabol.2017.11.002_bb0255","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1254\/jjp.78.385","article-title":"A comparative study on the effects of nicotine and GTS-21, a new nicotinic agonist, on the locomotor activity and brain monoamine level","volume":"78","author":"Nanri","year":"1998","journal-title":"Jpn J Pharmacol"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0260","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.neuropharm.2007.03.008","article-title":"Frontal cortical alpha7 and alpha4beta2 nicotinic acetylcholine receptors in working and reference memory","volume":"52","author":"Chan","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.metabol.2017.11.002_bb0265","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2013.01.004","article-title":"Activation of the alpha7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT(1)a receptor antagonist","volume":"70","author":"Pandya","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.metabol.2017.11.002_bb0270","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/psyg.12189","article-title":"Behavioural effects of PNU-282987 and stress in an animal model of Alzheimer's disease","volume":"17","author":"Vicens","year":"2017","journal-title":"Psychogeriatrics"},{"issue":"7","key":"10.1016\/j.metabol.2017.11.002_bb0275","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13213","article-title":"Cholinergic agonists reduce blood pressure in a mouse model of systemic lupus erythematosus","volume":"5","author":"Fairley","year":"2017","journal-title":"Physiol Rep"},{"issue":"8","key":"10.1016\/j.metabol.2017.11.002_bb0280","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.metabol.2015.10.032","article-title":"Exercise and diet in the management of nonalcoholic fatty liver disease","volume":"65","author":"Mahady","year":"2016","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.metabol.2017.11.002_bb0285","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1053\/j.gastro.2008.03.005","article-title":"The hepatic vagus nerve attenuates Fas-induced apoptosis in the mouse liver via alpha7 nicotinic acetylcholine receptor","volume":"134","author":"Hiramoto","year":"2008","journal-title":"Gastroenterology"},{"issue":"24","key":"10.1016\/j.metabol.2017.11.002_bb0290","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1016\/j.bmc.2006.09.019","article-title":"Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonists","volume":"14","author":"Walker","year":"2006","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"10.1016\/j.metabol.2017.11.002_bb0295","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/npp.2011.299","article-title":"Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia","volume":"37","author":"Brunzell","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"Pt A","key":"10.1016\/j.metabol.2017.11.002_bb0300","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuropharm.2016.07.010","article-title":"Selective activation of alpha7 nicotinic acetylcholine receptors augments hippocampal oscillations","volume":"110","author":"Stoiljkovic","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517303050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517303050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:15:22Z","timestamp":1758428122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049517303050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":60,"alternative-id":["S0026049517303050"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2017.11.002","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotinic acetylcholine receptor \u03b17 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2017.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}